NCT05281393View on ClinicalTrials.gov

PrEP2Prevent An Online PrEP Navigation and Activation Intervention

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 28, 2021

Primary Completion Date

June 20, 2023

Study Completion Date

January 3, 2024

Conditions
HIV Infections
Interventions
BEHAVIORAL

PrEPresent

PrEP2Prevent is being done in several phases (parts) to develop and pilot test a PrEP activation, navigation and support intervention for young men who have sex with men (YMSM), trans youth and non-binary youth in Los Angeles. It targets an intervention for these young people where they need it most - on PrEP uptake. PrEP stands for pre-exposure prophylaxis.

Trial Locations (1)

90027

Children's Hospital Los Angeles, Los Angeles

All Listed Sponsors
collaborator

Florida State University

OTHER

lead

Children's Hospital Los Angeles

OTHER

NCT05281393 - PrEP2Prevent An Online PrEP Navigation and Activation Intervention | Biotech Hunter | Biotech Hunter